RA CAPITAL MANAGEMENT, L.P.
Filing Date
Global Rank
#435
/ 8,603
▲ 44
· as of Mar 2026
Top Industry
Biotechnology
96.9%
3Y Alpha vs SPY
+9.4%
Period ended 3 months ago
Filed May 15, 2026 · 55d
25 quarters · since Mar 2020
Clone Performance
Jul 2023–Jul 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
+126.9%
SPY
+76.5%
Annualised alpha
+10.5%
Max drawdown
−48.8%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
84 positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025Top Position
24.9%
−1.3 pts
Top 5
47.3%
−2.3 pts
Top 10
61.3%
−4.5 pts
HHI
832
Diversified−96
Portfolio Trend
25 quarters · across all stocks
Sector Breakdown
As of Mar 31, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 99.8% | $9,410,140,868 |
| Financial Services | 0.2% | $20,927,500 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased
17 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| WVE | Wave Life Sciences Ltd. | +8,772,496 | 26,975,505 | $195,572,411 | |
| ABOS | Acumen Pharmaceuticals, Inc. | +6,060,606 | 20,992,669 | $49,542,698 | |
| SLDB | Solid Biosciences Inc. | +3,528,555 | 9,339,978 | $67,247,841 | |
| DSGN | Design Therapeutics, Inc. | +1,511,592 | 2,972,973 | $31,632,432 | |
| DNTH | Dianthus Therapeutics, Inc. /DE/ | +1,000,000 | 2,611,733 | $219,176,633 | |
| PCVX | Vaxcyte, Inc. | +750,000 | 11,474,599 | $666,788,947 | |
| NUVL | Nuvalent, Inc. | +654,088 | 2,534,145 | $259,623,155 | |
| IRON | Disc Medicine, Inc. | +474,089 | 2,450,221 | $156,667,130 | |
| WAY | Waystar Holding Corp. | +385,000 | 529,400 | $12,763,834 | |
| MLYS | Mineralys Therapeutics, Inc. | +369,000 | 7,692,750 | $208,396,597 | |
| BCAX | Bicara Therapeutics Inc. | +300,000 | 7,255,993 | $144,321,700 | |
| HNGE | Hinge Health, Inc. | +284,500 | 364,613 | $14,059,477 | |
| ACET | Adicet Bio, Inc. | +234,375 | 1,182,624 | $8,053,669 | |
| INSP | Inspire Medical Systems, Inc. | +183,699 | 325,663 | $16,797,697 | |
| WGS | GeneDx Holdings Corp. | +151,843 | 209,887 | $13,478,943 | |
| EVMN | Evommune, Inc. | +35,868 | 3,494,638 | $80,341,727 | |
| CLYM | Climb Bio, Inc. | +7,111 | 11,300,939 | $77,411,431 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter
24 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| SGP | SpyGlass Pharma, Inc. | 8,021,117 | $207,827,141 | |
| ZLAB | Zai Lab Ltd | 5,707,262 | $107,353,598 | |
| SRPT | Sarepta Therapeutics, Inc. | 3,902,596 | $84,920,488 | |
| DMRA | Damora Therapeutics, Inc. | 2,399,310 | $62,142,129 | |
| XNCR | Xencor Inc | 4,897,237 | $59,060,678 | |
| IPSC | Century Therapeutics, Inc. | 17,754,430 | $40,125,011 | |
| MIRM | Mirum Pharmaceuticals, Inc. | 318,554 | $29,428,018 | |
| BIOA | BioAge Labs, Inc. | 1,650,648 | $28,869,833 | |
| AKTS | Aktis Oncology, Inc. | 1,503,084 | $26,890,172 | |
| ALXO | Alx Oncology Holdings Inc | 13,011,849 | $26,088,757 | |
| ACRS | Aclaris Therapeutics, Inc. | 6,804,072 | $25,515,270 | |
| TVTX | Travere Therapeutics, Inc. | 746,841 | $22,188,646 | |
| RLMD | Relmada Therapeutics, Inc. | 2,947,369 | $20,513,688 | |
| DRUG | Bright Minds Biosciences Inc. | 265,000 | $19,337,050 | |
| STRO | Sutro Biopharma, Inc. | 715,307 | $17,818,297 | |
| AVR | Anteris Technologies Global Corp. | 3,000,000 | $16,650,000 | |
| OKUR | OnKure Therapeutics, Inc. | 3,998,333 | $16,553,098 | |
| HLXC | Helix Acquisition Corp. III | 1,250,000 | $12,700,000 | |
| RNA | Atrium Therapeutics, Inc. | 864,102 | $11,553,043 | |
| KPTI | Karyopharm Therapeutics Inc. | 1,917,354 | $10,679,661 | |
| CRVS | Corvus Pharmaceuticals, Inc. | 450,000 | $6,583,500 | |
| EQ | Equillium, Inc. | 3,096,336 | $6,192,672 | |
| MGNX | Macrogenics Inc | 1,864,176 | $5,387,468 | |
| MPLT | MapLight Therapeutics, Inc. | 248,294 | $5,047,817 | |
| No positions match the current search. | ||||
Sold Out
Positions the filer fully exited
7 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| ACLX | Arcellx, Inc. | 1,267,156 | $82,618,571 | |
| BLTE | Belite Bio, Inc | 432,484 | $69,180,140 | |
| IVVD | Invivyd, Inc. | 17,119,096 | $42,284,167 | |
| MDLN | Medline Inc. | 335,000 | $14,070,000 | |
| PGNY | Progyny, Inc. | 96,628 | $2,481,407 | |
| KIDS | Orthopediatrics Corp | 109,959 | $1,952,871 | |
| HCAT | Health Catalyst, Inc. | 793,749 | $1,897,060 | |
| No positions match the current search. | ||||
84 positions ·
$9,431,068,368 total
· as of Mar 31, 2026
Showing 1–50
of 84 positions by value
· page 1 of 2
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| ASND |
Ascendis Pharma A/S
Healthcare
|
Held | 10,281,496 | $2,351,686,580 | 24.94% | |
| PCVX |
Vaxcyte, Inc.
Healthcare
|
Added | 11,474,599 | $666,788,947 | 7.07% | |
| RYTM |
Rhythm Pharmaceuticals, Inc.
Healthcare
|
Held | 6,666,837 | $579,814,813 | 6.15% | |
| TYRA |
Tyra Biosciences, Inc.
Healthcare
|
Held | 12,198,625 | $467,207,337 | 4.95% | |
| SION |
Sionna Therapeutics, Inc.
Healthcare
|
Held | 9,905,045 | $397,093,254 | 4.21% | |
| EWTX |
Edgewise Therapeutics, Inc.
Healthcare
|
Held | 10,428,437 | $328,495,765 | 3.48% | |
| NAMS |
NewAmsterdam Pharma Co N.V.
Healthcare
|
Held | 9,550,191 | $305,701,613 | 3.24% | |
| NUVL |
Nuvalent, Inc.
Healthcare
|
Added | 2,534,145 | $259,623,155 | 2.75% | |
| DNTH |
Dianthus Therapeutics, Inc. /DE/
Healthcare
|
Added | 2,611,733 | $219,176,633 | 2.32% | |
| MLYS |
Mineralys Therapeutics, Inc.
Healthcare
|
Added | 7,692,750 | $208,396,597 | 2.21% | |
| SGP |
SpyGlass Pharma, Inc.
Healthcare
|
NEW | 8,021,117 | $207,827,141 | 2.20% | |
| WVE |
Wave Life Sciences Ltd.
Healthcare
|
Added | 26,975,505 | $195,572,411 | 2.07% | |
| SEPN |
Septerna, Inc.
Healthcare
|
Held | 6,995,858 | $168,110,467 | 1.78% | |
| IRON |
Disc Medicine, Inc.
Healthcare
|
Added | 2,450,221 | $156,667,130 | 1.66% | |
| JANX |
Janux Therapeutics, Inc.
Healthcare
|
Held | 11,189,693 | $155,536,732 | 1.65% | |
| BCRX |
Biocryst Pharmaceuticals Inc
Healthcare
|
Held | 15,827,186 | $150,674,810 | 1.60% | |
| BCAX |
Bicara Therapeutics Inc.
Healthcare
|
Added | 7,255,993 | $144,321,700 | 1.53% | |
| PRAX |
Praxis Precision Medicines, Inc.
Healthcare
|
Held | 373,787 | $120,430,433 | 1.28% | |
| GHRS |
GH Research PLC
Healthcare
|
Held | 7,676,697 | $107,934,359 | 1.14% | |
| ZLAB |
Zai Lab Ltd
Healthcare
|
NEW | 5,707,262 | $107,353,598 | 1.14% | |
| TSHA |
Taysha Gene Therapies, Inc.
Healthcare
|
Held | 23,555,648 | $105,293,746 | 1.12% | |
| VOR |
Vor Biopharma Inc.
Healthcare
|
Held | 5,404,998 | $96,425,164 | 1.02% | |
| GERN |
Geron Corp
Healthcare
|
Held | 63,771,366 | $95,019,335 | 1.01% | |
| SPRY |
ARS Pharmaceuticals, Inc.
Healthcare
|
Held | 10,860,977 | $87,213,645 | 0.92% | |
| SRPT |
Sarepta Therapeutics, Inc.
Healthcare
|
NEW | 3,902,596 | $84,920,488 | 0.90% | |
| SYRE |
Spyre Therapeutics, Inc.
Healthcare
|
Held | 1,621,620 | $81,794,512 | 0.87% | |
| EVMN |
Evommune, Inc.
Healthcare
|
Added | 3,494,638 | $80,341,727 | 0.85% | |
| CLYM |
Climb Bio, Inc.
Healthcare
|
Added | 11,300,939 | $77,411,431 | 0.82% | |
| SLDB |
Solid Biosciences Inc.
Healthcare
|
Added | 9,339,978 | $67,247,841 | 0.71% | |
| ARTV |
Artiva Biotherapeutics, Inc.
Healthcare
|
Held | 9,853,302 | $63,455,264 | 0.67% | |
| DMRA |
Damora Therapeutics, Inc.
Healthcare
|
NEW | 2,399,310 | $62,142,129 | 0.66% | |
| XNCR |
Xencor Inc
Healthcare
|
NEW | 4,897,237 | $59,060,678 | 0.63% | |
| LBRX |
Lb Pharmaceuticals Inc
Healthcare
|
Held | 2,208,604 | $54,464,174 | 0.58% | |
| JBIO |
Jade Biosciences, Inc.
Healthcare
|
Held | 3,671,083 | $51,578,716 | 0.55% | |
| ABOS |
Acumen Pharmaceuticals, Inc.
Healthcare
|
Added | 20,992,669 | $49,542,698 | 0.53% | |
| FDMT |
4D Molecular Therapeutics, Inc.
Healthcare
|
Reduced | 5,049,779 | $47,013,442 | 0.50% | |
| FULC |
Fulcrum Therapeutics, Inc.
Healthcare
|
Held | 6,053,960 | $46,433,873 | 0.49% | |
| CAPR |
Capricor Therapeutics, Inc.
Healthcare
|
Held | 1,507,844 | $45,838,457 | 0.49% | |
| IPSC |
Century Therapeutics, Inc.
Healthcare
|
NEW | 17,754,430 | $40,125,011 | 0.43% | |
| OLMA |
Olema Pharmaceuticals, Inc.
Healthcare
|
Held | 2,600,000 | $38,766,000 | 0.41% | |
| LENZ |
LENZ Therapeutics, Inc.
Healthcare
|
Held | 4,178,823 | $38,236,230 | 0.41% | |
| MNPR |
Monopar Therapeutics
Healthcare
|
Held | 667,207 | $36,556,271 | 0.39% | |
| PEPG |
PepGen Inc.
Healthcare
|
Held | 20,064,545 | $35,514,244 | 0.38% | |
| DSGN |
Design Therapeutics, Inc.
Healthcare
|
Added | 2,972,973 | $31,632,432 | 0.34% | |
| MIRM |
Mirum Pharmaceuticals, Inc.
Healthcare
|
NEW | 318,554 | $29,428,018 | 0.31% | |
| BIOA |
BioAge Labs, Inc.
Healthcare
|
NEW | 1,650,648 | $28,869,833 | 0.31% | |
| LXEO |
Lexeo Therapeutics, Inc.
Healthcare
|
Held | 5,000,000 | $28,700,000 | 0.30% | |
| ASMB |
Assembly Biosciences, Inc.
Healthcare
|
Held | 1,020,410 | $28,316,377 | 0.30% | |
| RZLT |
Rezolute, Inc.
Healthcare
|
Held | 9,180,000 | $27,999,000 | 0.30% | |
| AKTS |
Aktis Oncology, Inc.
Healthcare
|
NEW | 1,503,084 | $26,890,172 | 0.29% |